Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease
- PMID: 19532029
- DOI: 10.1097/MCP.0b013e328321861a
Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease
Abstract
Purpose of review: Pseudomonas aeruginosa is isolated in sputum cultures from adults with chronic obstructive pulmonary disease (COPD) but the significance of the organism in this clinical setting is not well known. The purpose of this review is to critically review the literature in an effort to understand the role of P. aeruginosa in the course and pathogenesis of COPD.
Recent findings: When examined longitudinally, two distinct patterns of carriage of P. aeruginosa are observed in adults with COPD: short-term colonization followed by clearance and long-term persistence. Acquisition of P. aeruginosa is associated with the occurrence of an exacerbation, indicating that the organism causes exacerbations. Exacerbations caused by P. aeruginosa are more likely to be seen in patients with more advanced COPD, those who have received recent antibiotic therapy and those who require mechanical ventilation for an exacerbation. A subset of adults with COPD becomes chronically colonized with P. aeruginosa, but whether such patients benefit from antimicrobial therapy is not yet known.
Summary: P. aeruginosa has several different manifestations in the setting of COPD. The organism is a colonizer that is cleared quickly, causes acute exacerbations and also may cause chronic infection in a subset of adults with COPD.
Similar articles
-
[Pseudomonas aeruginosa in chronic obstructive pulmonary disease].Rev Med Suisse. 2010 Nov 24;6(272):2240-3. Rev Med Suisse. 2010. PMID: 21207736 French.
-
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2008 Apr 15;177(8):853-60. doi: 10.1164/rccm.200709-1413OC. Epub 2008 Jan 17. Am J Respir Crit Care Med. 2008. PMID: 18202344
-
Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease.Clin Infect Dis. 2008 Dec 15;47(12):1526-33. doi: 10.1086/593186. Clin Infect Dis. 2008. PMID: 18990062
-
[The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease].Pol Merkur Lekarski. 2010 Apr;28(166):311-4. Pol Merkur Lekarski. 2010. PMID: 20491344 Review. Polish.
-
Chronic obstructive pulmonary disease and bronchiectasis.Curr Opin Pulm Med. 2013 Mar;19(2):133-9. doi: 10.1097/MCP.0b013e32835d8312. Curr Opin Pulm Med. 2013. PMID: 23287285 Review.
Cited by
-
Inhibition of Pseudomonas aeruginosa LPS-Induced airway inflammation by RIPK3 in human airway.J Cell Mol Med. 2022 Nov;26(21):5506-5516. doi: 10.1111/jcmm.17579. Epub 2022 Oct 13. J Cell Mol Med. 2022. PMID: 36226560 Free PMC article.
-
A putative ABC transporter, hatABCDE, is among molecular determinants of pyomelanin production in Pseudomonas aeruginosa.J Bacteriol. 2010 Nov;192(22):5962-71. doi: 10.1128/JB.01021-10. Epub 2010 Sep 24. J Bacteriol. 2010. PMID: 20870774 Free PMC article.
-
Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study.Int J Chron Obstruct Pulmon Dis. 2019 Oct 17;14:2365-2373. doi: 10.2147/COPD.S209513. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31802860 Free PMC article.
-
Identification of a lytic Pseudomonas aeruginosa phage depolymerase and its anti-biofilm effect and bactericidal contribution to serum.Virus Genes. 2019 Jun;55(3):394-405. doi: 10.1007/s11262-019-01660-4. Epub 2019 Apr 1. Virus Genes. 2019. PMID: 30937696
-
Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology.PLoS One. 2023 Aug 3;18(8):e0289609. doi: 10.1371/journal.pone.0289609. eCollection 2023. PLoS One. 2023. PMID: 37535697 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials